LMF2

Chr 22

lipase maturation factor 2

Also known as: TMEM112B, TMEM153

LMF2 encodes a protein involved in the maturation of specific proteins in the endoplasmic reticulum, particularly required for maturation and transport of lipoprotein lipase through the secretory pathway. Mutations cause lipoprotein lipase deficiency with severe hypertriglyceridemia, inherited in an autosomal recessive pattern. The gene shows low constraint against loss-of-function variants, consistent with the recessive inheritance pattern observed clinically.

ResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.94
Clinical SummaryLMF2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
143 unique Pathogenic / Likely Pathogenic· 202 VUS of 388 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.94LOEUF
pLI 0.000
Z-score -3.80
OE 1.68 (1.361.94)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-2.52Z-score
OE missense 1.34 (1.251.44)
577 obs / 429.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.68 (1.361.94)
00.351.4
Missense OE1.34 (1.251.44)
00.61.4
Synonymous OE1.64
01.21.6
LoF obs/exp: 61 / 36.3Missense obs/exp: 577 / 429.8Syn Z: -7.08
DN
0.6453th %ile
GOF
0.6637th %ile
LOF
0.3357th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

388 submitted variants in ClinVar

Classification Summary

Pathogenic142
Likely Pathogenic1
VUS202
Likely Benign16
Benign2
142
Pathogenic
1
Likely Pathogenic
202
VUS
16
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
142
0
142
Likely Pathogenic
0
0
1
0
1
VUS
0
186
16
0
202
Likely Benign
0
11
1
4
16
Benign
0
0
2
0
2
Total01971624363

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LMF2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗